PMI Japan Launches KT&G lil HYBRID 3.0 Device

Apr.03
PMI Japan Launches KT&G lil HYBRID 3.0 Device
PMJ introduces new lil HYBRID 3.0 device by KT&G, set to launch in Japan through various channels in April 2025.

Key points:

Philip Morris International (PMI) Japan has launched the "lil HYBRID 3.0" heated tobacco device manufactured by KT&G from South Korea.

The product will be available for sale starting on April 15, 2025, through the official IQOS website, four IQOS stores nationwide, and several retail channels, priced at 3980 Japanese yen (27 USD) including tax.

In January 2023, KT&G renewed a 15-year supply contract with PMI to sell its three HNB products through PMI's global network (excluding South Korea).


According to a report from Dime.jp on April 3, Philip Morris International (PMI) Japan announced the launch of a new heat-not-burn tobacco device called "lil HYBRID 3.0," manufactured by KT&G in South Korea. The product will be available starting April 15, 2025, through the official IQOS website, four IQOS stores nationwide, and various retail channels, priced at 3,980 Japanese yen (including tax) (27 USD).

 

PMJ stated at the product launch event, "PMJ will continue to strive to provide products and services with higher satisfaction for smokers aged 20 and above, in order to achieve the vision of a 'smoke-free society'.

 

In January 2023, KT&G and PMI signed a renewed 15-year supply contract. KT&G will distribute its three HNB products, "lil Solid," "lil Hybrid," and "lil Aible," through PMI's global sales networks outside of Korea. 

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Dutch Medical Institutions Urge Snapchat to Crack Down on E-cigarette Sales Content
Dutch Medical Institutions Urge Snapchat to Crack Down on E-cigarette Sales Content
Several Dutch medical and public health organizations have jointly sent a letter to Snapchat, urging the platform to strengthen its efforts in curbing e-cigarette promotion to protect youth from nicotine addiction. If no improvement is seen within 14 days, a formal complaint will be filed.
Jun.12 by 2FIRSTS.ai
Ukraine Dismisses E-Cigarette Retail Violation Case Citing Procedural Flaws and Insufficient Evidence
Ukraine Dismisses E-Cigarette Retail Violation Case Citing Procedural Flaws and Insufficient Evidence
The Rivne Court of Appeal in Ukraine has overturned an administrative penalty in a case involving the sale of e-cigarette e-liquids, citing insufficient evidence and procedural irregularities. The court ruled that the original decision failed to prove the defendant’s wrongdoing beyond reasonable doubt, leading to the cancellation of the fine.
May.13 by 2FIRSTS.ai
U.S. FDA Unveils AI Tool Elsa for Clinical Review, Internal Writing, and Data Processing
U.S. FDA Unveils AI Tool Elsa for Clinical Review, Internal Writing, and Data Processing
The U.S. Food and Drug Administration has officially launched Elsa, a generative AI tool designed to speed up clinical reviews, internal writing, and data processing tasks. After successful pilots across multiple departments, Elsa is now being rolled out agency-wide.
Jun.04 by 2FIRSTS.ai
GFN Experts Warn: Misinformation is Killing Smokers
GFN Experts Warn: Misinformation is Killing Smokers
At the 2025 Global Forum on Nicotine in Warsaw, experts warned that misinformation about nicotine and safer alternatives is misleading the public and healthcare professionals, hindering smokers’ access to life-saving products.
Jun.27
Zimbabwe's 2025 Tobacco Sales Reach 280 Million kg, Near 300 Million Target
Zimbabwe's 2025 Tobacco Sales Reach 280 Million kg, Near 300 Million Target
Zimbabwe has sold over 280 million kg of tobacco in the 2025 season, 94% of its 300 million kg target, earning $944 million. TIMB says 108,000 farmers took part, up 4.6% from last year. The Agriculture Ministry credits good weather, more smallholders, better practices, and contract farming. The average price is $3.37/kg, slightly down from 2024 but still profitable.
Jun.17 by 2FIRSTS.ai
Tobacco Giants Speak on THR at GFN: Calling for Regulatory Reform Aligned with Scientific Understanding
Tobacco Giants Speak on THR at GFN: Calling for Regulatory Reform Aligned with Scientific Understanding
At the GFN 2025, representatives from the world’s four largest tobacco companies emphasized the need for science-driven harm reduction policies. They urged regulators to move beyond outdated approaches and adopt consumer-focused, evidence-based frameworks to better serve public health goals.
Jun.26